Summary | |
---|---|
Symbol | CISH |
Name | cytokine inducible SH2-containing protein |
Aliases | CIS; CIS-1; SOCS; BACTS2; cytokine-inducible inhibitor of signaling type 1B; suppressor of cytokine signalin ...... |
Chromosomal Location | 3p21.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | - |
Domain |
PF00017 SH2 domain PF07525 SOCS box |
Function |
SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. CIS is involved in the negative regulation of cytokines that signal through the JAK-STAT5 pathway such as erythropoietin, prolactin and interleukin 3 (IL3) receptor. Inhibits STAT5 trans-activation by suppressing its tyrosine phosphorylation. May be a substrate-recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (By similarity). |
Biological Process |
GO:0001558 regulation of cell growth GO:0001933 negative regulation of protein phosphorylation GO:0006469 negative regulation of protein kinase activity GO:0007205 protein kinase C-activating G-protein coupled receptor signaling pathway GO:0007259 JAK-STAT cascade GO:0008286 insulin receptor signaling pathway GO:0016049 cell growth GO:0032868 response to insulin GO:0032869 cellular response to insulin stimulus GO:0033673 negative regulation of kinase activity GO:0042326 negative regulation of phosphorylation GO:0043434 response to peptide hormone GO:0046425 regulation of JAK-STAT cascade GO:0046426 negative regulation of JAK-STAT cascade GO:0046626 regulation of insulin receptor signaling pathway GO:0046627 negative regulation of insulin receptor signaling pathway GO:0051348 negative regulation of transferase activity GO:0071375 cellular response to peptide hormone stimulus GO:0071417 cellular response to organonitrogen compound GO:0097696 STAT cascade GO:1900076 regulation of cellular response to insulin stimulus GO:1900077 negative regulation of cellular response to insulin stimulus GO:1901652 response to peptide GO:1901653 cellular response to peptide GO:1902532 negative regulation of intracellular signal transduction GO:1904892 regulation of STAT cascade GO:1904893 negative regulation of STAT cascade |
Molecular Function |
GO:0004857 enzyme inhibitor activity GO:0004860 protein kinase inhibitor activity GO:0019207 kinase regulator activity GO:0019210 kinase inhibitor activity GO:0019887 protein kinase regulator activity |
Cellular Component | - |
KEGG |
hsa04630 Jak-STAT signaling pathway hsa04917 Prolactin signaling pathway |
Reactome |
R-HSA-1280215: Cytokine Signaling in Immune system R-HSA-982772: Growth hormone receptor signaling R-HSA-168256: Immune System |
Summary | |
---|---|
Symbol | CISH |
Name | cytokine inducible SH2-containing protein |
Aliases | CIS; CIS-1; SOCS; BACTS2; cytokine-inducible inhibitor of signaling type 1B; suppressor of cytokine signalin ...... |
Chromosomal Location | 3p21.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between CISH and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
Literatures describing the relation between CISH and anti-tumor immunity in human cancer.
|
Summary | |
---|---|
Symbol | CISH |
Name | cytokine inducible SH2-containing protein |
Aliases | CIS; CIS-1; SOCS; BACTS2; cytokine-inducible inhibitor of signaling type 1B; suppressor of cytokine signalin ...... |
Chromosomal Location | 3p21.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of CISH in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | CISH |
Name | cytokine inducible SH2-containing protein |
Aliases | CIS; CIS-1; SOCS; BACTS2; cytokine-inducible inhibitor of signaling type 1B; suppressor of cytokine signalin ...... |
Chromosomal Location | 3p21.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of CISH in various data sets.
|
Points in the above scatter plot represent the mutation difference of CISH in various data sets.
|
Summary | |
---|---|
Symbol | CISH |
Name | cytokine inducible SH2-containing protein |
Aliases | CIS; CIS-1; SOCS; BACTS2; cytokine-inducible inhibitor of signaling type 1B; suppressor of cytokine signalin ...... |
Chromosomal Location | 3p21.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of CISH. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | CISH |
Name | cytokine inducible SH2-containing protein |
Aliases | CIS; CIS-1; SOCS; BACTS2; cytokine-inducible inhibitor of signaling type 1B; suppressor of cytokine signalin ...... |
Chromosomal Location | 3p21.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of CISH. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by CISH. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | CISH |
Name | cytokine inducible SH2-containing protein |
Aliases | CIS; CIS-1; SOCS; BACTS2; cytokine-inducible inhibitor of signaling type 1B; suppressor of cytokine signalin ...... |
Chromosomal Location | 3p21.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of CISH. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | CISH |
Name | cytokine inducible SH2-containing protein |
Aliases | CIS; CIS-1; SOCS; BACTS2; cytokine-inducible inhibitor of signaling type 1B; suppressor of cytokine signalin ...... |
Chromosomal Location | 3p21.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of CISH expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | CISH |
Name | cytokine inducible SH2-containing protein |
Aliases | CIS; CIS-1; SOCS; BACTS2; cytokine-inducible inhibitor of signaling type 1B; suppressor of cytokine signalin ...... |
Chromosomal Location | 3p21.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between CISH and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | CISH |
Name | cytokine inducible SH2-containing protein |
Aliases | CIS; CIS-1; SOCS; BACTS2; cytokine-inducible inhibitor of signaling type 1B; suppressor of cytokine signalin ...... |
Chromosomal Location | 3p21.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting CISH collected from DrugBank database. |
There is no record. |